Viewing Study NCT02075034


Ignite Creation Date: 2025-12-25 @ 2:23 AM
Ignite Modification Date: 2026-03-05 @ 5:08 AM
Study NCT ID: NCT02075034
Status: WITHDRAWN
Last Update Posted: 2020-07-01
First Post: 2014-02-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Three Dosing Schedules of Oral Rigosertib in MDS Patients
Sponsor: Traws Pharma, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myelodysplastic syndrome View
None MDS View
None Low risk View
None Intermediate-1 risk View
None Intermediate-2 risk View
None International Prognostic Scoring System View
None IPSS View